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ABSTRACT
Drug-induced gingival overgrowth (GO) has been associated with phenytoin, cyclosporine, and calcium channel blocker 
therapies. This study reports the case of an 11-year-old girl who was referred for evaluation of GO, which had occurred 
over the last 6 months. Her medical history included a liver transplant due to biliary atresia 3 years ago, immunosuppressive 
therapy, and hypertension, which is why she was started on a daily intake of amlodipine. The intraoral examination 
showed generalized GO, and the treatment consisted of a gingivectomy. Subsequently, amlodipine was replaced with 
captopril and oral hygiene instructions. There was no recurrence of GO after 28 months of follow-up. Although GO may 
be related to the chronic use of amlodipine, such an association is uncommon in pediatrics, and the treatment consists 
of the replacement of medication combined with a surgical approach and plaque control. 
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INTRODUCTION
Liver transplantation is the current treatment 
for end stage chronic liver disease and acute hepatic 
failure, even though it is a very demanding procedure. 
The most frequent indications are biliary atresia, 
fulminant liver failure, metabolic diseases, hepatic 
tumors, cirrhosis, and other cholestatic liver diseases. 
Liver-transplanted children have shown good overall 
patient/organ survival rates of 83.8/75.3% after 3 years, 
and 70.2/65.1% after 5 years of transplantation. 
This increase in survival time is mainly due to the 
improvement of surgical techniques, the management 
of complications, immunosuppressive medications, and 
multidisciplinary intervention.1,2
L i ve r  t r ansp lan t  comp l i ca t ions  may  be 
associated with the surgical procedure, infections, 
and immunosuppressive therapy. Tacrol imus, 
cyclosporine, and corticosteroids are most often 
used to prevent graft rejection.3,4 Calcium-channel 
blockers, such as nifedipine and amlodipine, are usually 
recommended for the treatment of hypertension 
after liver transplantation,5-8 since this complication 
represents a possible side effect associated with the 
immunosuppressive regimen.
In 1993, Ellis et al.9 first reported gingival 
overgrowth (GO) associated with the chronic 
use of calcium channel blockers; since then, its 
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prevalence has been reported in nearly 3% of patients. 
The enlargement of the gingiva may hamper the 
appropriate oral hygiene, predisposing tooth decay 
and periodontal infections, requiring rigorous plaque 
control, anti-hypertensive drug schedule replacement, 
and surgical correction for aesthetic purposes.10,11
Although a liver transplant is commonly associated 
with cardiovascular alterations and the use amlodipine 
is not infrequent, to date, only a single report has 
shown the involvement of GO in a young patient after 
solid organ transplantation.12 The objective of this case 
study is to describe such an association in a child, and 
how this was managed.
CASE REPORT
An 11-year-old girl was referred to the Stomatology 
Department due to gingival enlargement. The patient 
reported slow and progressive growth of the gums 
over the last 6 months. Her medical history included 
a liver transplant to treat biliary atresia when she was 
8 years old. Since then, she had been using tacrolimus 
(0.25 mg once a week) and prednisone (10 mg daily)—
to avoid organ graft rejection—and amlodipine 
(10 mg/day) for blood pressure control.
Her dental history showed no particular treatment 
and she had regular visits to the dentist. The oral 
hygiene was proper and no dental caries was observed. 
However, many white spots were present in almost 
all teeth, which is consistent with enamel hypoplasia. 
In addition, an extensive fibrous GO in the anterior 
permanent teeth of both arches was observed. 
Such GO mainly affected the marginal gingiva, but also 
it affected the interdental papilla and covered the tooth 
crown 4 mm on average with standard color, without 
any inflammatory component. There was no bleeding 
during periodontal probing (Figure 1). The diagnostic 
suspicion was amlodipine-related GO. The treatment 
consisted of oral care instructions (the use of a soft 
brush at least three times a day and dental floss) and 
a gingivectomy.
The surgery was performed under general 
anesthesia by two stomatologists after a preoperative 
work-up and an anesthetic evaluation. The internal 
bevel technique was used to remove all the gingival 
hyperplastic tissue, involving the anterior region of 
both dental arches. The patient received antibiotics 
(clindamycin) for a total of 7 days, and an analgesic 
(dipyrone) for 3 days. The postoperative period was 
uneventful, and she was discharged after 2 days of 
hospitalization. The histopathological features showed 
hyperkeratosis, acanthosis, and some long epithelial 
rete pegs. In addition, intense fibrosis of the connective 
tissue and an increase in the number of blood vessels 
with slight chronic perivascular inflammation were 
observed (Figure 2).
The amlodipine was replaced by captopril. After 
28 months of follow-up, there was no GO recurrence 
(Figure 3).
DISCUSSION
Although the survival rate of pediatric patients 
who undergo liver transplantations has substantially 
increased due to the immunosuppressive therapy, 
these drugs always have been associated with many 
complications and side effects. In this context, GO 
had been described in children who had undergone 
kidney or liver transplants. It was also associated with 
the long-term use of cyclosporine, nifedipine, and 
amlodipine, and is similar to the well-known side 
effect of the anticonvulsant, such as phenytoin.9,10,13,14 
The case reported here showed an 11-year-old girl who 
developed GO after 30 months of amlodipine use.
Calcium channel blockers act directly on vascular 
smooth muscle, reducing systemic vascular resistance 
and improving renal blood flow, thereby reducing 
the systemic blood pressure.15 Some studies11,16,17 
showed the incidence of GO ranging between 1.3% 
Figure 1. Intraoral examination showing GO in the 
anterior region of both arches.
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Figure 2. Photomicrography of the gingiva showing the histopathological features of the amlodipine-related GO. 
A - Slight hyperkeratosis, acanthosis, and B - long epithelial rete pegs; C - Intense fibrosis of the connective tissue, 
and D - an increased number of capillaries with slight chronic perivascular inflammation (H&E, 150X).
Figure 3. Intraoral examination after 28 months of follow-up, with no recurrence of gingival overgrowth. A - Anterior 
view; B - Occlusal view; C - Right side view; and D - Left side view.
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and 3.4% in hypertensive adults using amlodipine for 
at least 3 months. These drugs also have been used 
for hypertension control in post-liver transplantation 
patients. Interestingly, a higher frequency of GO 
was observed in patients simultaneously taking 
cyclosporine and calcium channel blockers (46.7%) 
compared to patients taking tacrolimus and calcium 
channel blockers (8.3%).18 Based on the study of 
Shiboski et al.,19 tacrolimus was not related to GO, and, 
similar to his findings, in our institution, none of the 
children who underwent liver transplantation who were 
treated with tacrolimus presented GO.13 Furthermore, 
neither James et al.20 nor Greenberg et al.21 found any 
association between the use of tacrolimus and GO in 
renal transplant patients. However, Cezário et al.22 and 
Paixao et al.23 related an association rate of 7.25% 
and 8.3%, respectively. In our case, the diagnosis of 
amlodipine-induced GO was established.
The pathogenesis of GO related to medications 
still remains unclear. However, a hypothesis involving 
anti-convulsants, calcineurin inhibitors, and calcium 
channel blockers has recently been described in a 
review14 that states that the cation flux reduces the 
folic acid active transport in gingival fibroblasts, 
causing the reduction of cellular folate uptake. 
The matrix metalloproteinase metabolism is changed, 
which impairs the collagenase activation and results 
in the increase of collagen synthesis. In addition, the 
presence of inflammation caused by bacterial plaque 
also induces connective tissue production.14
Poor hygiene, local inflammation, and bleeding 
also may be associated with GO. The anterior region 
is the most affected by GO, and the local factor, 
such as bacterial plaque, may exacerbate such cases, 
increasing susceptibility to oral infections, dental caries, 
and periodontal diseases.9,10,24 Similarly, the present 
patient was affected by GO in the anterior region 
of both arches, especially in the interdental papillae, 
without local factors, such as the presence of plaque 
and/or gingival bleeding.
The treatment of this condition is the replacement 
of the “guilty drug,” which, in our case, was the 
amlodipine combined with removal of bacterial plaque 
if present. For aesthetic reasons, surgical intervention 
is recommended. The classic surgical approach of 
the internal bevel may be used in a gingivectomy.10,24 
This technique is based on the principle of excising 
the tissue that is extended with a scalpel blade tilted 
at an angle of 45 degrees in relation to the teeth, also 
contouring the papillae. Afterwards, interpapillary 
suturing must be performed to maintain the papillary 
position. The patient in this case report was successfully 
treated with the change of amlodipine to captopril and 
by undergoing a gingivectomy.
CONCLUSION
The present case illustrates the diagnosis and 
management of GO associated with the use of 
amlodipine. In addition, children who have undergone 
a solid-organ transplant should have periodic follow-up 
with dentists due to oral side effects related to 
immunosuppressive therapy and other drugs, such as 
amlodipine.
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